ONXX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Onyx Pharmaceuticals, Inc.'s total equity for the quarter that ended in Jun. 2013 was $1,143.6 Mil.
Total equity is used to calculate book value per share. Onyx Pharmaceuticals, Inc.'s book value per share for the quarter that ended in Jun. 2013 was $15.65. The ratio of a companys debt over equity can be used to measure how leveraged this company is. Onyx Pharmaceuticals, Inc.'s debt to equity ratio for the quarter that ended in Jun. 2013 was 0.16.
Total Equity refers to the net assets owned by shareholders.
Total Equity and Total Liabilities are the two components for Total Assets.
Onyx Pharmaceuticals, Inc.'s Total Equity for the fiscal year that ended in Dec. 2012 is calculated as
Onyx Pharmaceuticals, Inc.'s Total Equity for the quarter that ended in Jun. 2013 is calculated as
|Total Equity||=||Total Assets(Q: Jun. 2013 )||-||Total Liabilities(Q: Jun. 2013 )|
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
1. Total equity is used to calculate book value per share.
Onyx Pharmaceuticals, Inc.'s Book Value Per Share for the quarter that ended in Jun. 2013 is
|Book Value per Share||=||(Total Shareholders Equity||-||Preferred Stock)||/||Total Shares Outstanding|
2. The ratio of a companys debt over equity can be used to measure how leveraged this company is.
Onyx Pharmaceuticals, Inc.'s Debt to Equity Ratio for the quarter that ended in Jun. 2013 is
|Debt to Equity||=||Total Debt||/||Total Equity|
|=||(Current Portion of Long-Term Debt||+||Long-Term Debt)||/||Total Equity|
Total Assets, Total Liabilities, Preferred Stock, Common Stock, Retained Earnings, Treasury Stock, Book Value per Share, Total Shares Outstanding, Current Portion of Long-Term Debt, Long-Term Debt, Additional Paid-In Capital
Onyx Pharmaceuticals, Inc. Annual Data
Onyx Pharmaceuticals, Inc. Quarterly Data
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.